(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)
Blood Pressure Drug Recalled Over Mislabeling Error
Patients taking lercanidipine for high blood pressure are being urged to check their medication after a labeling error on a batch of tablets. The MHRA says 20mg tablets were incorrectly labelled as 10mg on some packs made by Recordati Pharmaceuticals.
Over 7,700 packs are affected, with batch number MD4L07 and an expiry date of January 2028. The blister strips inside show the correct dose, but the front of the box does not. The batch was distributed from 10 April.
Patients prescribed 20mg tablets should verify the dose on the blister. Those prescribed 10mg should contact their GP or pharmacist immediately, or call NHS 111. If unable to reach a professional, half a 20mg tablet may be taken temporarily.
Pharmacists are being asked to stop supplying and return the affected batch. Suspected side effects should be reported via the MHRA’s Yellow Card scheme.
21-04-2025